Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neurofibromatosis 1 6 Neoplasm Metastasis 6 Solid Tumours 5 Neoplasms 5 Melanoma 5 Neurofibroma, Plexiform 4 Lung Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Solid Tumors 1 Renal Insufficiency 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Muscle Invasive Bladder Cancer 1 Locally Advanced or Metastatic Solid Tumors 1 Kidney Neoplasms 1 Healthy Volunteers Pharmacokinetic Study 1 Disease Progression 1 Differentiated Thyroid Cancer 1 Colonic Neoplasms 1 Advanced Non Small Cell Lung Cancer 1 Advanced Cancer 1

Interventions

Nivolumab 19 Ipilimumab 9 linrodostat 6 relatlimab 4 Pemetrexed 4 Paclitaxel 4 Carboplatin 4 ARRY-334543 4 Docetaxel 3 regorafenib 2 anlotinib 2 abemaciclib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Gemcitabine 2 Cyclophosphamide 2 Capecitabine 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 trametinib 1 tislelizumab 1 sargramostim 1 ralimetinib 1 prexasertib 1 palifosfamide lysine 1 p38 Mitogen-Activated Protein Kinases 1 mirdametinib 1 lirilumab 1 indibulin 1 gedatolisib 1 fluzoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Cancer × AZD 6244 × Clear all

NCT00085787 2020-10-14

A Study of ARRY-142886 in Patients With Advanced Cancer

Array BioPharma

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡